Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes

BACKGROUND: Berberine is an isoquinoline alkaloid widely used to improve the glucidic and lipidic profiles of patients with hypercholesterolemia, metabolic syndrome, and type 2 diabetes. The limitation of berberine seems to be its poor oral bioavailability, which is affected by the presence, in ente...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Pierro, Francesco, Putignano, Pietro, Villanova, Nicola, Montesi, Luca, Moscatiello, Simona, Marchesini, Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838471/
https://www.ncbi.nlm.nih.gov/pubmed/24277991
http://dx.doi.org/10.2147/CPAA.S54308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838471/
https://www.ncbi.nlm.nih.gov/pubmed/24277991
http://dx.doi.org/10.2147/CPAA.S54308

Ejemplares similares